Literature DB >> 20181302

Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy.

Silvio Bellino1, Camilla Rinaldi, Filippo Bogetto.   

Abstract

OBJECTIVE: Combined treatment with interpersonal psychotherapy (IPT) and antidepressants (ADs) has been found more effective than single pharmacotherapy in patients with major depression and concomitant borderline personality disorder (BPD). The aim of our study is to investigate whether combined treatment with a modified version of IPT is still superior to ADs when treating patients with a single diagnosis of BPD.
METHOD: Fifty-five consecutive outpatients with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, diagnosis of BPD were enrolled. They were randomly assigned to 2 treatment arms for 32 weeks: fluoxetine 20 to 40 mg per day plus clinical management; and fluoxetine 20 to 40 mg per day plus IPT adapted to BPD (IPT-BPD). Eleven patients (20%) discontinued treatment owing to noncompliance. Forty-four patients completed the treatment period. They were assessed at baseline, and at week 16 and 32 with: a semi-structured interview for demographic and clinical variables; Clinical Global Impression Scale (CGI-S); Hamilton Depression Rating Scale (HDRS); Hamilton Anxiety Rating Scale (HARS); Social and Occupational Functioning Assessment Scale (SOFAS); BPD Severity Index (BPD-SI); and a questionnaire for quality of life (Satisfaction Profile [SAT-P]). A univariate general linear model was performed with 2 factors: duration and type of treatment. P values of less than 0.05 were considered significant.
RESULTS: Remission rates did not differ significantly between subgroups. Duration, but not type of treatment, had a significant effect on CGI-S, HDRS, SOFAS, and total BPD-SI score changes. Combined therapy was more effective on the HARS; the items: interpersonal relationships, affective instability, and impulsivity of BPD-SI; and the factors: psychological functioning and social functioning of SAT-P.
CONCLUSIONS: Combined therapy with adapted IPT was superior to fluoxetine alone in BPD patients, concerning a few core symptoms of the disorder, anxiety, and quality of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181302     DOI: 10.1177/070674371005500203

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  9 in total

Review 1.  State of the art in the pharmacologic treatment of borderline personality disorder.

Authors:  Louis Feurino; Kenneth R Silk
Journal:  Curr Psychiatry Rep       Date:  2011-02       Impact factor: 5.285

Review 2.  Pharmacotherapy for borderline personality disorder--current evidence and recent trends.

Authors:  Jutta M Stoffers; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

Review 3.  A Focused Systematic Review of Pharmacological Treatment for Borderline Personality Disorder.

Authors:  Ella Hancock-Johnson; Chris Griffiths; Marco Picchioni
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

4.  The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy.

Authors:  Jessica C Levenson; Meredith L Wallace; Jay C Fournier; Paola Rucci; Ellen Frank
Journal:  J Consult Clin Psychol       Date:  2012-07-23

Review 5.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 6.  Borderline personality disorder and depression: an update.

Authors:  Maria Luca; Antonina Luca; Carmela Calandra
Journal:  Psychiatr Q       Date:  2012-09

7.  Non-response to psychotherapy for borderline personality disorder: A systematic review.

Authors:  Jane Woodbridge; Michelle Townsend; Samantha Reis; Saniya Singh; Brin Fs Grenyer
Journal:  Aust N Z J Psychiatry       Date:  2021-09-15       Impact factor: 5.598

8.  Psychological therapies for people with borderline personality disorder.

Authors:  Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen
Journal:  Cochrane Database Syst Rev       Date:  2020-05-04

9.  Treatment of borderline personality disorder and co-occurring anxiety disorders.

Authors:  Melanie S Harned; Helen R Valenstein
Journal:  F1000Prime Rep       Date:  2013-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.